Who is the new CEO of Proteomics International Laboratories?

David Morris has been appointed as the new CEO and managing director of Proteomics International Laboratories.

What is the Promarker diagnostics suite?

The Promarker diagnostics suite is a precision diagnostics pipeline developed by Proteomics International Laboratories.

What recent achievement did Proteomics International's US lab secure?

Proteomics International's US Reference Laboratory in Irvine, California, secured accreditation from the College of American Pathologists.

Home / Business and Economy / New CEO Tapped for Diagnostics Firm

New CEO Tapped for Diagnostics Firm

14 Jan

•

Summary

David Morris appointed CEO of Proteomics International Laboratories.
Morris brings extensive healthcare and medtech executive experience.
Focus on commercial rollout of Promarker diagnostics suite.

Proteomics International Laboratories has welcomed David Morris as its new Chief Executive Officer and Managing Director. Morris brings a wealth of experience from previous leadership roles at prominent healthcare and medtech companies, including Cochlear and Nanosonics.

His mandate is to spearhead the commercial rollout of the company's innovative Promarker diagnostics suite. Morris's proven track record in driving commercial growth and international expansion is seen as critical for accelerating the Promarker precision diagnostics pipeline.

The appointment occurs shortly after the company's US Reference Laboratory in Irvine, California, achieved accreditation from the College of American Pathologists, marking a significant milestone for the firm's operations.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.